Center Of Target Therapy
Clinical trials sponsored by Center Of Target Therapy, explained in plain language.
-
New drug combo aims to wipe out hepatitis c in Hard-to-Treat patients
Disease control OngoingThis study follows 30 adults with chronic hepatitis C (genotype 3) and mild to moderate liver fibrosis who are taking ravidasvir and sofosbuvir as part of their regular care. Researchers will check if the virus is undetectable 12 weeks after treatment ends (SVR12). The goal is to…
Sponsor: Center of target therapy • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Fatty liver drug hope: semaglutide shows promise in Long-Term study
Disease control OngoingThis study looks at how well the diabetes drug semaglutide works for people with metabolic fatty liver disease (MAFLD) and liver scarring. About 70 adults will take the drug for 3 years as part of their regular care. The goal is to see if it can reduce liver fat, inflammation, an…
Sponsor: Center of target therapy • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC